Literature DB >> 8514259

Bile acid synthesis from newly synthesized vs. preformed cholesterol precursor pools in the rat.

J Scheibner1, M Fuchs, M Schiemann, G Tauber, E Hörmann, E F Stange.   

Abstract

The present study defines the origin of cholesterol subserving bile acid synthesis in male rats with an extracorporal bile duct by labeling newly formed cholesterol with tritiated water. Within 6 hr after interruption of the enterohepatic circulation, the bile acid pool was depleted. At this early time point the proportion from de novo cholesterol was 8% and 12% for biliary cholesterol and cholate, but 18% and 19% for muricholate and chenodeoxycholate, respectively. This proportion gradually rose to 40%, 34%, 51% and 51%, respectively, at 15 to 30 hr. At 78 hr after bile diversion, 64% of cholate was labeled, compared with 84% to 88% of the other biliary lipids and 71% of plasma cholesterol. Total and labeled bile acid secretion exhibited the same diurnal rhythm. To allow differentiation between direct hepatocytic de novo synthesis of bile acids from acetate and recycling of labeled plasma cholesterol, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (pravastatin) was infused from 54 to 78 hr. It suppressed total synthesis of primary bile acids by 60% to 80% but decreased the tritium label of bile acids only from a range of 74% to 92% (54 hr) to a range of 54% to 63% (78 hr), which was in the range of plasma cholesterol (58%). We conclude that bile acids and biliary cholesterol are synthesized mostly from preformed (i.e., plasma) cholesterol, both immediately after depletion of the pool in enterohepatic circulation and after derepression. Moreover, the hepatic cholesterol pools subserving the synthesis of different bile acids and biliary cholesterol secretion are not identical.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514259

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Short-term effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor on cholesterol and bile acid synthesis in humans.

Authors:  T Yoshida; A Honda; J Shoda; M Abei; Y Matsuzaki; N Tanaka; H Miyazaki; T Osuga
Journal:  Lipids       Date:  1997-08       Impact factor: 1.880

2.  The contribution of newly synthesized cholesterol to biliary cholesterol in healthy humans.

Authors:  J Scheibner; K Lange; K Empen; E F Stange
Journal:  Z Ernahrungswiss       Date:  1997-12

3.  Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice.

Authors:  Zidong Donna Fu; Julia Yue Cui; Curtis D Klaassen
Journal:  J Lipid Res       Date:  2014-10-02       Impact factor: 5.922

4.  Contribution of newly synthesized cholesterol to rat plasma and bile determined by mass isotopomer distribution analysis: bile-salt flux promotes secretion of newly synthesized cholesterol into bile.

Authors:  R H Bandsma; F Stellaard; R J Vonk; G T Nagel; R A Neese; M K Hellerstein; F Kuipers
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

5.  Heterogeneous expression of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase genes in the rat liver lobulus.

Authors:  J Twisk; M F Hoekman; W H Mager; A F Moorman; P A de Boer; L Scheja; H M Princen; R Gebhardt
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

6.  Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease.

Authors:  Olga Renner; Dieter Lütjohann; Dominique Richter; André Strohmeyer; Silke Schimmel; Oliver Müller; Eduard F Stange; Simone Harsch
Journal:  BMC Gastroenterol       Date:  2013-02-13       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.